biopharma

Sanofi to buy US biopharma group Blueprint for up to US$9.5 billion
June 2, 2025
[PARIS] France’s Sanofi has agreed to buy US-based Blueprint Medicines Corporation for up to US$9.5 billion to boost its position in rare immunology diseases, in the biggest deal struck...